<DOC>
	<DOCNO>NCT01000987</DOCNO>
	<brief_summary>The purpose study examine effect varenicline reactivity high dose ( 0.08 g/dL ) alcohol ( vs. placebo alcohol ) ascend descend limb blood alcohol curve .</brief_summary>
	<brief_title>Effect Varenicline Fixed-Dose Alcohol Administration Participants With Alcohol Use Disorders</brief_title>
	<detailed_description />
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>21 year old old Able read write English Smokers nonsmoker Meet criterion alcohol use disorder Currently enrol NCT00580645 Any significant current medical psychiatric condition would contraindicate consumption alcohol Significant hepatocellular injury Positive test result intake appointment urine drug screen conduct opiate , cocaine , benzodiazepine Women pregnant nursing Suicidal , homicidal , evidence severe mental illness Prescription psychotropic drug 30 day prior study enrollment Blood donation within past 8 week Individuals seek treatment drink smoking attempt quit drinking smoking within past 3 month Known allergy varenicline take H2blockers Participation within past 8 week study involve additive blood sample and/or interventional measure would consider excessive combination current protocol Subjects likely exhibit clinically significant alcohol withdrawal study</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>alcohol</keyword>
	<keyword>reactivity</keyword>
	<keyword>smoke cessation medication</keyword>
</DOC>